Glasgow Coma Scale ≤ 12 at Admission is a Predictor of Poor Functional Outcome (mRS 2-6) at One Year in Patients with Cerebral Venous Thrombosis.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 21 01 2021
revised: 21 03 2021
accepted: 01 04 2021
pubmed: 30 4 2021
medline: 17 6 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

To determine factors at hospitalization of cerebral venous thrombosis (CVT) which determine outcome at one year. This was an ambispective study with outcome at one year follow up. Patients angiographically proven as CVT were included in study and functional modified Rankin Scale (mRS) determined at one year. They were dichotomized into "good" outcome (mRS 0-1) and "poor" outcome (mRS 2-6). Variables at admission were compared on univariate and then by cox proportional hazard regression for significance. Complications during follow up period were also compared. One hundred and seventy five patients were included, data of 71 was collected prospectively. One hundred and seventeen (66.9%) had "good" outcome while 58 (33.1%) had "poor" outcome. Univariate analysis showed poor outcome associated with age < 30 years, female sex, focal deficit, GCS ≤ 12, ≥3 sinuses involved and intracerebral haemorrhage. On Cox proportional hazard regression only GCS ≤ 12 was significant. Around 96% had complete/ partial recanalization at 6 months. Over one year, the complications included dural AV fistula in 10 (5.7%), intracranial hypertension in 4 (2.3%), venous thromboembolism in 6 (3.4%) and arterial infarct in 4 (2.3%). Proportions with complications in each group were similar. At one year 41 patients (25.2%) were continued on anticoagulation and 97 (55.2%) on antiepileptic drugs. Proportion in each group were similar. In patients with CVT, GCS ≤ 12 at admission was a predictor of poor functional outcome (mRS 2-6) at one year. During this period, complications were few and similar in the both the groups.

Identifiants

pubmed: 33915391
pii: S1052-3057(21)00214-7
doi: 10.1016/j.jstrokecerebrovasdis.2021.105811
pii:
doi:

Substances chimiques

Anticoagulants 0
Anticonvulsants 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105811

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None

Auteurs

Salil Gupta (S)

Dept of Neurology, Army Hospital Research and Referral, Delhi Cantt, New Delhi, 110010, India. Electronic address: chickusalil@yahoo.com.

Rahul Soni (R)

Dept of Neurology, Army Hospital Research and Referral, Delhi Cantt, New Delhi, 110010, India.

Pawan Dhull (P)

Dept of Neurology, Army Hospital Research and Referral, Delhi Cantt, New Delhi, 110010, India.

Manoj Somasekharan (M)

Dept of Neurology, Army Hospital Research and Referral, Delhi Cantt, New Delhi, 110010, India.

Amit Sreen (A)

Dept of Neurology, Army Hospital Research and Referral, Delhi Cantt, New Delhi, 110010, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH